Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1953 2
1954 2
1955 1
1957 1
1958 4
1959 6
1960 6
1961 12
1962 4
1963 6
1964 2
1965 2
1966 3
1967 3
1968 5
1969 5
1971 3
1972 2
1973 3
1974 1
1975 3
1977 1
1978 5
1979 5
1980 2
1981 5
1983 4
1984 3
1985 6
1986 7
1987 4
1988 12
1989 2
1990 8
1991 13
1992 8
1993 13
1994 20
1995 19
1996 13
1997 13
1998 13
1999 20
2000 21
2001 17
2002 18
2003 24
2004 18
2005 24
2006 22
2007 18
2008 26
2009 32
2010 34
2011 40
2012 50
2013 42
2014 35
2015 41
2016 49
2017 34
2018 38
2019 41
2020 41
2021 43
2022 37
2023 32
2024 29

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

983 results

Results by year

Filters applied: . Clear all
Page 1
Neisseria gonorrhoeae host adaptation and pathogenesis.
Quillin SJ, Seifert HS. Quillin SJ, et al. Among authors: seifert hs. Nat Rev Microbiol. 2018 Apr;16(4):226-240. doi: 10.1038/nrmicro.2017.169. Epub 2018 Feb 12. Nat Rev Microbiol. 2018. PMID: 29430011 Free PMC article. Review.
Gonorrhoea.
Unemo M, Seifert HS, Hook EW 3rd, Hawkes S, Ndowa F, Dillon JR. Unemo M, et al. Among authors: seifert hs. Nat Rev Dis Primers. 2019 Nov 21;5(1):79. doi: 10.1038/s41572-019-0128-6. Nat Rev Dis Primers. 2019. PMID: 31754194 Review.
Ceftobiprole for Treatment of Complicated Staphylococcus aureus Bacteremia.
Holland TL, Cosgrove SE, Doernberg SB, Jenkins TC, Turner NA, Boucher HW, Pavlov O, Titov I, Kosulnykov S, Atanasov B, Poromanski I, Makhviladze M, Anderzhanova A, Stryjewski ME, Assadi Gehr M, Engelhardt M, Hamed K, Ionescu D, Jones M, Saulay M, Smart J, Seifert H, Fowler VG Jr; ERADICATE Study Group. Holland TL, et al. Among authors: seifert h. N Engl J Med. 2023 Oct 12;389(15):1390-1401. doi: 10.1056/NEJMoa2300220. Epub 2023 Sep 27. N Engl J Med. 2023. PMID: 37754204 Free article. Clinical Trial.
Acinetobacter baumannii: emergence of a successful pathogen.
Peleg AY, Seifert H, Paterson DL. Peleg AY, et al. Among authors: seifert h. Clin Microbiol Rev. 2008 Jul;21(3):538-82. doi: 10.1128/CMR.00058-07. Clin Microbiol Rev. 2008. PMID: 18625687 Free PMC article. Review.
Discovery of highly neutralizing human antibodies targeting Pseudomonas aeruginosa.
Simonis A, Kreer C, Albus A, Rox K, Yuan B, Holzmann D, Wilms JA, Zuber S, Kottege L, Winter S, Meyer M, Schmitt K, Gruell H, Theobald SJ, Hellmann AM, Meyer C, Ercanoglu MS, Cramer N, Munder A, Hallek M, Fätkenheuer G, Koch M, Seifert H, Rietschel E, Marlovits TC, van Koningsbruggen-Rietschel S, Klein F, Rybniker J. Simonis A, et al. Among authors: seifert h. Cell. 2023 Nov 9;186(23):5098-5113.e19. doi: 10.1016/j.cell.2023.10.002. Epub 2023 Nov 1. Cell. 2023. PMID: 37918395 Free article.
A global view on carbapenem-resistant Acinetobacter baumannii.
Müller C, Reuter S, Wille J, Xanthopoulou K, Stefanik D, Grundmann H, Higgins PG, Seifert H. Müller C, et al. Among authors: seifert h. mBio. 2023 Dec 19;14(6):e0226023. doi: 10.1128/mbio.02260-23. Epub 2023 Oct 26. mBio. 2023. PMID: 37882512 Free PMC article.
Oritavancin: an update.
Flüh G, Seifert H, Kaasch AJ. Flüh G, et al. Among authors: seifert h. Future Microbiol. 2018 Jun 1;13:727-729. doi: 10.2217/fmb-2017-0310. Epub 2018 May 25. Future Microbiol. 2018. PMID: 29799267 No abstract available.
Reply by Authors.
Bausch K, Halbeisen FS, Aghlmandi S, Sutter SU, Ewald H, Appenzeller-Herzog C, Roth JA, Widmer AF, Seifert HH. Bausch K, et al. Among authors: seifert hh. J Urol. 2021 Apr;205(4):998. doi: 10.1097/JU.0000000000001513.03. Epub 2021 Feb 3. J Urol. 2021. PMID: 33533646 No abstract available.
Defining persistent Staphylococcus aureus bacteraemia: secondary analysis of a prospective cohort study.
Kuehl R, Morata L, Boeing C, Subirana I, Seifert H, Rieg S, Kern WV, Kim HB, Kim ES, Liao CH, Tilley R, Lopez-Cortés LE, Llewelyn MJ, Fowler VG, Thwaites G, Cisneros JM, Scarborough M, Nsutebu E, Gurgui Ferrer M, Pérez JL, Barlow G, Hopkins S, Ternavasio-de la Vega HG, Török ME, Wilson P, Kaasch AJ, Soriano A; International Staphylococcus aureus collaboration study group and the ESCMID Study Group for Bloodstream Infections, Endocarditis and Sepsis. Kuehl R, et al. Among authors: seifert h. Lancet Infect Dis. 2020 Dec;20(12):1409-1417. doi: 10.1016/S1473-3099(20)30447-3. Epub 2020 Aug 4. Lancet Infect Dis. 2020. PMID: 32763194
Early oral switch therapy in low-risk Staphylococcus aureus bloodstream infection (SABATO): study protocol for a randomized controlled trial.
Kaasch AJ, Fätkenheuer G, Prinz-Langenohl R, Paulus U, Hellmich M, Weiß V, Jung N, Rieg S, Kern WV, Seifert H; SABATO trial group (with linked authorship to the individuals in the Acknowledgements section). Kaasch AJ, et al. Among authors: seifert h. Trials. 2015 Oct 9;16:450. doi: 10.1186/s13063-015-0973-x. Trials. 2015. PMID: 26452342 Free PMC article. Clinical Trial.
983 results